Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3',4,5'-Tetramethoxystilbene. (2022)
Attributed to:
Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14102046
PubMed Identifier: 36297480
Publication URI: http://europepmc.org/abstract/MED/36297480
Type: Journal Article/Review
Volume: 14
Parent Publication: Pharmaceutics
Issue: 10
ISSN: 1999-4923